These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19682865)

  • 21. Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings.
    Versijpt J; Van Laere KJ; Dumont F; Decoo D; Vandecapelle M; Santens P; Goethals I; Audenaert K; Slegers G; Dierckx RA; Korf J
    Neurobiol Aging; 2003; 24(4):553-61. PubMed ID: 12714112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
    Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
    Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
    J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy.
    Stamelou M; Matusch A; Elmenhorst D; Hurlemann R; Eggert KM; Zilles K; Oertel WH; Höglinger GU; Bauer A
    Mov Disord; 2009 Jun; 24(8):1170-5. PubMed ID: 19353726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding.
    Frokjaer VG; Erritzoe D; Juul A; Nielsen FA; Holst K; Svarer C; Madsen J; Paulson OB; Knudsen GM
    Psychoneuroendocrinology; 2010 Oct; 35(9):1311-20. PubMed ID: 20356681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.
    Simpson HB; Slifstein M; Bender J; Xu X; Hackett E; Maher MJ; Abi-Dargham A
    Biol Psychiatry; 2011 Nov; 70(9):897-904. PubMed ID: 21855857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia.
    Verhoeff NP; Meyer JH; Kecojevic A; Hussey D; Lewis R; Tauscher J; Zipursky RB; Kapur S
    Psychiatry Res; 2000 Oct; 99(3):123-35. PubMed ID: 11068194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
    Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
    Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Greater loss of 5-HT(2A) receptors in midlife than in late life.
    Sheline YI; Mintun MA; Moerlein SM; Snyder AZ
    Am J Psychiatry; 2002 Mar; 159(3):430-5. PubMed ID: 11870007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.
    Hautzel H; Müller HW; Herzog H; Grandt R
    Neuroimage; 2011 Oct; 58(3):905-11. PubMed ID: 21722741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
    Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
    J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep deprivation increases cerebral serotonin 2A receptor binding in humans.
    Elmenhorst D; Kroll T; Matusch A; Bauer A
    Sleep; 2012 Dec; 35(12):1615-23. PubMed ID: 23204604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.
    Li Y; Huang XF; Deng C; Meyer B; Wu A; Yu Y; Ying W; Yang GY; Yenari MA; Wang Q
    Synapse; 2010 Mar; 64(3):224-30. PubMed ID: 19862688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia.
    Hurlemann R; Boy C; Meyer PT; Scherk H; Wagner M; Herzog H; Coenen HH; Vogeley K; Falkai P; Zilles K; Maier W; Bauer A
    Anat Embryol (Berl); 2005 Dec; 210(5-6):519-23. PubMed ID: 16187138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.
    Quednow BB; Treyer V; Hasler F; Dörig N; Wyss MT; Burger C; Rentsch KM; Westera G; Schubiger PA; Buck A; Vollenweider FX
    Neuroimage; 2012 Feb; 59(4):3922-32. PubMed ID: 21996132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans.
    Matusch A; Hurlemann R; Rota Kops E; Winz OH; Elmenhorst D; Herzog H; Zilles K; Bauer A
    J Neural Transm (Vienna); 2007; 114(11):1433-42. PubMed ID: 17541696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and.
    Soares JC; van Dyck CH; Tan P; Zoghbi SS; Garg P; Soufer R; Baldwin RM; Fujita M; Staley JK; Fu X; Amici L; Seibyl J; Innis RB
    Psychiatry Res; 2001 Apr; 106(2):81-93. PubMed ID: 11306248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
    Meyer PT; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM; Hinz R
    Neuroimage; 2010 Apr; 50(3):984-93. PubMed ID: 20083209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
    Hasselbalch SG; Madsen K; Svarer C; Pinborg LH; Holm S; Paulson OB; Waldemar G; Knudsen GM
    Neurobiol Aging; 2008 Dec; 29(12):1830-8. PubMed ID: 17544547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.